Jan 26, 2024
“The search for daunorubicin’s sister really led to this discovery of doxorubicin, which is an analog with much greater activity. The discovery of doxorubicin can be coined kind of as, ‘one of the best drugs born in Milan, Italy.’ And after that, a few analogs were developed and tested, and two that we...
Jan 19, 2024
“So much of this is just knowing what is their diagnosis, what medications are they on, what could be the root cause of this—where is their disease to begin with? There's really a lot of differential diagnosis and workup that has to be thought about, you know, when you're dealing with shortness of breath and...
Jan 12, 2024
“AYAs are underrepresented in clinical trials and unfortunately have one of the highest rates of being uninsured of any population. So, this is really concerning for a lot of reasons and really impacts our ability to make a difference for their treatment and outcomes,” Stacy Whiteside, APRN, MS, CPNP-AC/PC, CPON
Jan 5, 2024
“I can think of examples where I have two patients. They have the same diagnosis, but they have two different insurance companies, treatment plan’s the same. ‘Patient A’ isn't going to get the optimal treatment plan because their insurance company won't approve it. ‘Patient B’ is going to get the...